GIOSTAR, A Cell Therapy and Research Institution is Leading Development of Therapies for Cancer, Metabolic and Degenerative Diseases
GIOSTAR is the world’s leading stem cell research institution located in San Diego, California, USA, and has been involved in stem cell research work for over 20 years. GIOSTAR’s team of scientists and clinicians has been involved in the development and utilization of clinical protocols related to stem cell transplants.
They have the capability to treat several devastating immunological diseases and blood-related diseases. These include Diabetes Type I and Type II, Lupus, Multiple Sclerosis, Crohn’s disease, Vasculitis, Scleroderma, Myasthenia Gravis, Sickle Cell Anemia, Leukemia, Lymphoma, Thalassemia and developing the therapies for Alzheimer’s disease, autism, anti-aging treatments, Parkinson’s disease, cancer, heart, and retinal degeneration, amyotrophic lateral sclerosis, neuropathy, osteoarthritis, paralysis, strokes, spinal cord injuries, skin burns and spinal muscular atrophy (SMA).
The company uses adult stem cells for its autologous and allogeneic stem cell therapy to treat patients. They have also generated blood stem cells from stem cells, which may have abilities to manage blood-related diseases such as betathalassemia and sickle cell anemia. Today, the company is a leading private organization with state-of-the-art excellence in the extraction of stem cells from the human body for therapeutic application.
Their patients normally suffer from metabolic diseases, cancer, and degenerative diseases. GIOSTAR has developed clinical protocols of stem cell therapies for treating autoimmune, degenerative, and metabolic diseases. They have also developed immune-therapy protocols for treating cancer.
Know More : Global-Business-Icons-2022 – Dr. Anand Srivastava